Search Results - "Hind Hamzeh-Cognasse"

Refine Results
  1. 1
  2. 2

    Quality assessment of red blood cell concentrates from blood donors at the extremes of the age spectrum: The BEST collaborative study by Cloutier, Marc, Cognasse, Fabrice, Yokoyama, Ana Paula Hitomi, Hazegh, Kelsey, Mykhailova, Olga, Brandon‐Coatham, Mackenzie, HamzehCognasse, Hind, Kutner, Jose Mauro, Acker, Jason P., Kanias, Tamir

    Published in Transfusion (Philadelphia, Pa.) (01-08-2023)
    “…Background Blood donors at the extremes of the age spectrum (16–19 years vs. ≥75 years) are characterized by increased risks of iron deficiency and anemia, and…”
    Get full text
    Journal Article
  3. 3

    DAMPS and complement activation in platelet concentrates that induce adverse reactions in patients by Wit, Yasmin E. S., HamzehCognasse, Hind, Cognasse, Fabrice, Brinke, Anja, Zeerleder, Sacha S.

    Published in Transfusion (Philadelphia, Pa.) (01-09-2022)
    “…Background Patients with severe thrombocytopenia due to bone marrow failure and after chemotherapy are still treated with platelet transfusions. Platelet…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Inhibition of the CD40/CD40L complex protects mice against ALI‐induced pancreas degradation by Tariket, Sofiane, HamzehCognasse, Hind, Arthaud, Charles‐Antoine, Laradi, Sandrine, Bourlet, Thomas, Berthelot, Philippe, Garraud, Olivier, Cognasse, Fabrice

    Published in Transfusion (Philadelphia, Pa.) (01-03-2019)
    “…BACKGROUND Acute lung injury (ALI) is a severe complication of transfusion. In a previous study, we saw that inhibition of the CD40/CD40L complex allowed…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets by Cognasse, Fabrice, HamzehCognasse, Hind, Lafarge, Sandrine, Delezay, Olivier, Pozzetto, Bruno, McNicol, Archie, Garraud, Olivier

    Published in British journal of haematology (01-04-2008)
    “…Summary Blood platelets link the processes of haemostasis and inflammation. This study examined the immunomodulatory factors released by platelets after…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Revisiting Platelets and Toll-Like Receptors (TLRs): At the Interface of Vascular Immunity and Thrombosis by Hally, Kathryn, Fauteux-Daniel, Sebastien, Hamzeh-Cognasse, Hind, Larsen, Peter, Cognasse, Fabrice

    “…While platelet function has traditionally been described in the context of maintaining vascular integrity, recent evidence suggests that platelets can modulate…”
    Get full text
    Journal Article
  12. 12

    Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword by Ebermeyer, Théo, Cognasse, Fabrice, Berthelot, Philippe, Mismetti, Patrick, Garraud, Olivier, Hamzeh-Cognasse, Hind

    “…Platelets are hematopoietic cells whose main function has for a long time been considered to be the maintenance of vascular integrity. They have an essential…”
    Get full text
    Journal Article
  13. 13

    Platelet Inflammatory Response to Stress by Cognasse, Fabrice, Laradi, Sandrine, Berthelot, Philippe, Bourlet, Thomas, Marotte, Hubert, Mismetti, Patrick, Garraud, Olivier, Hamzeh-Cognasse, Hind

    Published in Frontiers in immunology (28-06-2019)
    “…Blood platelets play a central hemostatic role, (i) as they repair vascular epithelial damage, and (ii) they play immune defense roles, as they have the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Platelets as Key Factors in Inflammation: Focus on CD40L/CD40 by Cognasse, Fabrice, Duchez, Anne Claire, Audoux, Estelle, Ebermeyer, Theo, Arthaud, Charles Antoine, Prier, Amelie, Eyraud, Marie Ange, Mismetti, Patrick, Garraud, Olivier, Bertoletti, Laurent, Hamzeh-Cognasse, Hind

    Published in Frontiers in immunology (03-02-2022)
    “…Platelets are anucleate cytoplasmic fragments derived from the fragmentation of medullary megakaryocytes. Activated platelets adhere to the damaged endothelium…”
    Get full text
    Journal Article
  16. 16

    Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases by Heestermans, Marco, Poenou, Géraldine, Duchez, Anne-Claire, Hamzeh-Cognasse, Hind, Bertoletti, Laurent, Cognasse, Fabrice

    “…Venous thromboembolism (VTE) is the third leading cardiovascular cause of death and is conventionally treated with anticoagulants that directly antagonize…”
    Get full text
    Journal Article
  17. 17

    Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection by Hamzeh-Cognasse, Hind, Mansour, Alexandre, Reizine, Florian, Mismetti, Patrick, Gouin-Thibault, Isabelle, Cognasse, Fabrice

    Published in Virology journal (29-10-2021)
    “…The SARS-CoV-2 virus is the causing agent of the Coronavirus disease 2019 (COVID-19) characterized by a huge pro-inflammatory response and coagulation…”
    Get full text
    Journal Article
  18. 18

    Key topographic parameters driving surface adhesion of Porphyromonas gingivalis by Papa, Steve, Maalouf, Mathieu, Claudel, Pierre, Sedao, Xxx, Di Maio, Yoan, Hamzeh-Cognasse, Hind, Thomas, Mireille, Guignandon, Alain, Dumas, Virginie

    Published in Scientific reports (23-09-2023)
    “…Dental implant failure is primarily due to peri-implantitis, a consequence of bacterial biofilm formation. Bacterial adhesion is strongly linked to…”
    Get full text
    Journal Article
  19. 19

    The signaling role of CD40 ligand in platelet biology and in platelet component transfusion by Aloui, Chaker, Prigent, Antoine, Sut, Caroline, Tariket, Sofiane, Hamzeh-Cognasse, Hind, Pozzetto, Bruno, Richard, Yolande, Cognasse, Fabrice, Laradi, Sandrine, Garraud, Olivier

    “…The CD40 ligand (CD40L) is a transmembrane molecule of crucial interest in cell signaling in innate and adaptive immunity. It is expressed by a variety of…”
    Get full text
    Journal Article Book Review
  20. 20

    Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications by Heestermans, Marco, Poenou, Géraldine, Hamzeh-Cognasse, Hind, Cognasse, Fabrice, Bertoletti, Laurent

    Published in Cells (Basel, Switzerland) (13-10-2022)
    “…Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent) venous thromboembolism (VTE). Drugs to prevent clotting have been used…”
    Get full text
    Journal Article